Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
Authorized on
Authorized
Remaining
Expires
Terms
26-Oct-26
$630m
$630mEST
n/a
On October 26, 2026, the Company’s board of trustees approved an increase to the Company’s Common Share repurchase authorization from $500 million to $630 million (the “share repurchase program”).10-Q filed 03-Nov-26
Open-market repurchases
Repurchased per month, USD (≈ shares × average price)